Results 101 to 110 of about 11,686 (228)

HIPEC for ovarian cancer

, 2021
Eierstokkanker staat in de top 10 van kankerdiagnoses bij vrouwen wereldwijd. Ongeveer 70-80% van de patiënten met eierstokkanker, heeft deze ziekte in stadium III of IV, waarbij de ziekte is uitgezaaid naar het buikvlies of buiten de buikholte. De behandeling van eierstokkanker bestaat uit chirurgie, chemotherapie en doelgerichte onderhoudstherapie ...
openaire   +2 more sources

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles

Cancer Management and Research, 2020
Yuxin Zhong,1 Jing Zhang,2 Xiaofeng Bai,1 Yuemin Sun,1 Hao Liu,1 Shuai Ma,1 Yang Li,1 Wenzhe Kang,1 Fuhai Ma,1 Weikun Li,1 Yantao Tian1 1Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer ...
Zhong Y, Zhang J, Bai X, Sun Y, Liu H, Ma S, Li Y, Kang W, Ma F, Li W, Tian Y   +10 more
doaj  

Evaluation of the feasibility, safety, and preliminary effectiveness of hyperthermic intraperitoneal chemotherapy following radical surgery for locally advanced gastric cancer

Frontiers in Oncology
ObjectiveTo explore the feasibility, safety, and potential association between hyperthermic intraperitoneal chemotherapy (HIPEC) and peritoneal recurrence in patients with locally advanced gastric cancer following D2 radical surgery.Materials and ...
Tianze Zhang, Hang Yu, Lang Wang, Shijun Zhao, Cheng Zhao, Jie Chai, Dehai Wang   +6 more
doaj   +1 more source

Update on colorectal carcinomatosis - from molecular biology to diagnosis and management [PDF]

, 2013
After liver metastases, Peritoneal Carcinomatosis (PC) is the second most frequent cause of death in patients with Co-lorectal Cancer (CRC), although the precise incidence of Colorectal Cancer Peritoneal Carcinomatosis is not known, as the majority of ...
Longatto Filho, Adhemar, Martins, Sandra
core  

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source

Perioperative Management for Colorectal Peritoneal Metastases [PDF]

, 2018
Kim, Bradford J., Passot, Guillaume
core   +1 more source

Implementation of an enhanced recovery after surgery (ERAS) program in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: study protocol for a prospective multicenter interventional trial (EPICH study)

Pleura and Peritoneum
This study aims to evaluate the clinical impact of introducing an Enhanced Recovery After Surgery (ERAS) protocol in the management of patients undergoing cytoreductive surgery (CRS), with or without hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella Manuela, Pagano Eva, Giacometti Lisa, Cinquegrana Armando, Pellegrino Luca, Evangelista Andrea, Saliva Alessandra, Cerutti Alessandro, Borghi Felice   +8 more
doaj   +1 more source

Implantación en Mallorca de un programa de Tratamiento multimodal de la Carcinomatosis Peritoneal mediante Quimioterapia Sistémica, Cirugía Citorreductora y Quimioterapia Intraperitoneal Hipertérmica (HIPEC) [PDF]

, 2012
Introducción: Las investigaciones de Sugarbaker et al demostraron desde principios de los 90 que muchos tumores de origen colorrectal y apendicular con extensión peritoneal pueden permanecer limitados al abdomen durante períodos relativamente largos ...
Arrivi García-Ramos, Antonio, Francisco Noguera, José, Morales Soriano, Rafael   +2 more
core  

Construction of sensitive quality index system of perioperative nursing during hyperthermic intraperitoneal chemotherapy

Huli yanjiu
ObjectiveTo construct a sensitive quality indicators system for hyperthermic intraperitoneal chemotherapy（HIPEC），and provide a scientific tool for improving nursing quality.MethodsBased on the theoretical basis of "structure⁃process⁃outcome" quality ...
XIAO Xueying, HUANG Yulin, LI Yanmei, WANG Haoyun   +3 more
doaj  

HIPEC

Ovarian cancer is the third most common and deadliest gynecologic cancer. The lack of specific symptoms often leads to delayed diagnosis and advanced disease with extensive peritoneal metastases. Hyperthermic intraperitoneal chemotherapy (HIPEC) is a technique in which heated chemotherapy is delivered into the abdominal cavity after cytoreductive ...
openaire   +2 more sources